Showing results (191-200 of 731) with videos related to

Sort By:
Pageof 74
Lancet (London, England)|September 12, 2021
Immune checkpoint inhibitors in melanomaMatteo S Carlino, James Larkin, Georgina V Long
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Cell Reports. Medicine|February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trialJames Larkin, Richard Marais, Nuria Porta, et al.
Expert Opinion on Drug Safety|March 7, 2014
Prospects for MEK inhibitors for treating cancerJuan Martin-Liberal, Laura Lagares-Tena, James Larkin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2024
Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still OutAndreas Michael Schmitt, James Larkin, Sapna P Patel
The Oncologist|October 25, 2011
Integrating molecular mechanisms and clinical evidence in the management of trastuzumab resistant or refractory HER-2⁺ metastatic breast cancerHilda Wong, Roland Leung, Ava Kwong, et al.
Annual Review of Genetics|October 9, 2014
Cancer: evolution within a lifetimeMarco Gerlinger, Nicholas McGranahan, Sally M Dewhurst, et al.
European Urology|August 28, 2016
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven TherapeuticsChristopher E Barbieri, Arul M Chinnaiyan, Seth P Lerner, et al.
The Journal of Pathology|February 25, 2012
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic targetMarco Gerlinger, Claudio R Santos, Bradley Spencer-Dene, et al.
Stem Cell Research|November 16, 2024
Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC)Liani G Devito, Eugénie S Lim, Samuel M O'Toole, et al.
Pageof 74